Oncology and Cancer

welcome message

Dear Esteemed Participants,

Join us at the 6^th International Conference on Oncology and Cancer, a globally recognized platform where innovation, research, and clinical excellence come together to advance the future of cancer care.

Taking place in the iconic city of Paris, this conference brings together leading oncologists, researchers, clinicians, academicians, and industry experts from across the globe. This year’s edition focuses on cutting-edge advancements that are transforming the way we understand, diagnose, and treat cancer.

From precision medicine and immunotherapy to AI-driven diagnostics and personalized treatment strategies, the conference is designed to deliver insights that are not only ground breaking but also directly applicable in clinical and research settings.

Thanks & Regards
Organizing Committee

Participation / Presentation Options

The conference offers flexible opportunities for participants to engage, present, and contribute based on their interests and professional goals:

• Oral Presentation: Present your research or case studies in a dedicated session to a global audience of experts, followed by interactive discussions and feedback.
• Poster Presentation: Showcase your research findings in a visual format, allowing for one-on-one discussions and networking with attendees and experts.
• Keynote Presentation: Deliver a high-impact talk as an invited expert, sharing advanced insights, innovations, and leadership perspectives in oncology.
• Workshop/Symposium: Conduct or participate in specialized sessions focusing on specific themes, techniques, or emerging areas in cancer research and treatment.
• Virtual Presentation: For those unable to attend in person, present your work online and engage with the global audience remotely.
• Delegate Participation: Attend the conference to gain knowledge, network with professionals, and explore the latest developments without presenting.
• Exhibitor/Sponsor Opportunities: Organizations and companies can showcase their products, technologies, and services while connecting with key stakeholders and decision-makers.
• Each participation option is designed to maximize learning, visibility, and collaboration in the field of oncology and cancer research.

About the Conference

The 6^th International Conference on Oncology and Cancer, scheduled for November 24–25, 2026, in Paris, France, is a premier global platform dedicated to advancing the understanding and treatment of cancer through innovation, collaboration, and scientific excellence. This conference will bring together leading oncologists, researchers, clinicians, academicians, and industry professionals to discuss ground breaking research, emerging therapies, and the latest technological advancements in oncology. Attendees will gain valuable insights into precision medicine, immunotherapy, targeted treatments, early detection strategies, and patient-centered care, all aimed at improving outcomes and transforming the future of cancer management.

Theme: Transforming Cancer Care: AI, Precision Medicine, and Global Innovations for a Cure

With a strong focus on integrating cutting-edge research with real-world clinical applications, the conference aims to foster meaningful discussions and collaborations that address current challenges in oncology. It will serve as a dynamic forum for knowledge exchange, networking, and showcasing novel approaches that enhance diagnosis, treatment, and survivorship. By uniting global expertise under one roof, this event aspires to accelerate progress in cancer care and contribute to a future where effective, accessible, and personalized treatment becomes a reality for all patients.

Why to Attend?

Attending this conference offers a powerful combination of knowledge, collaboration, and global exposure:

• Gain in-depth insights into the latest advancements in oncology, including precision medicine, immunotherapy, targeted therapies, and innovative cancer diagnostics.
• Engage with leading oncologists, researchers, clinicians, and industry experts from across Europe and around the world.
• Expand your professional network by connecting with decision-makers, academic leaders, and healthcare innovators.
• Showcase your research to an international audience and enhance your academic and professional recognition.
• Access sessions covering cutting-edge topics such as cancer genomics, early detection technologies, radiotherapy advancements, AI in oncology, and personalized treatment approaches.
• Participate in interactive workshops and panel discussions designed to translate research into real-world clinical practice.
• Explore opportunities for collaborations, research partnerships, and career advancement in the global oncology community.

Experience the cultural and scientific excellence of Paris while being part of a globally impactful cancer conference.

What Attendees Will Gain

Advanced Knowledge

Gain in-depth understanding of the latest advancements in oncology, including precision medicine, immunotherapy, and AI-driven cancer care.

 Global Networking
Build meaningful connections with leading oncologists, researchers, clinicians, and industry professionals from around the world.

 Research & Collaboration Opportunities
Explore potential collaborations, research partnerships, and opportunities that support academic and professional growth.

 Practical Insights
Acquire evidence-based knowledge and real-world strategies applicable to clinical practice and research environments.

 Industry Trends & Innovations
Stay informed about emerging trends, technological advancements, and innovations shaping the future of cancer diagnosis and treatment.

Sessions & Tracks

Track 1: Cancer Biology & Tumor Microenvironment

This track focuses on the fundamental biological mechanisms driving cancer development and progression. It explores the complex interactions between tumor cells and their surrounding microenvironment, including immune and stromal components. Key areas include tumor heterogeneity, angiogenesis, hypoxia, and immune evasion. Recent advances in molecular oncology will be highlighted to understand cancer growth and resistance to therapies. The session also emphasizes the impact of the microenvironment on treatment outcomes. Emerging technologies used to study tumor ecosystems will be discussed. Insights into identifying novel therapeutic targets will be presented. Overall, this track aims to support the development of more effective and targeted cancer treatments.

Track 2: AI & Machine Learning in Oncology

This track highlights the transformative role of artificial intelligence and machine learning in cancer care. It covers AI-driven diagnostics, predictive analytics, and clinical decision support systems. Discussions include imaging analysis, pathology automation, and real-time data interpretation. The session also explores how AI enhances treatment planning and patient outcomes. Ethical considerations and data privacy challenges will be addressed. Integration of AI into clinical workflows will be emphasized. Participants will gain insights into future in AI innovations oncology. Overall, this track focuses on smarter, faster, and more accurate cancer care solutions.

Track 3: Precision Medicine & Personalized Cancer Treatment

This track focuses on tailoring cancer treatments based on individual genetic and molecular profiles. It highlights advances in targeted therapies and patient-specific treatment strategies. Discussions include biomarker-driven approaches and customized drug selection. The role of genomics in improving treatment efficacy will be explored. Challenges in implementing personalized medicine will also be addressed. The session emphasizes improved patient outcomes and reduced side effects. Emerging tools enabling precision oncology will be showcased. Overall, it promotes a patient-centric approach to cancer care.

Track 4: Cancer Genomics, Epigenetics & Biomarkers

This track explores the genetic and epigenetic alterations driving cancer development. It focuses on biomarker discovery for early detection and targeted therapy. Discussions include DNA mutations, gene expression, and epigenetic modifications. The role of biomarkers in diagnosis and prognosis will be highlighted. Advances in sequencing technologies will be covered. The session also addresses challenges in clinical translation. Participants will gain insights into precision diagnostics. Overall, this track supports the advancement of personalized oncology.

Track 5: Immunotherapy & Targeted Therapy Advances

This track covers breakthroughs in immunotherapy and targeted cancer treatments. It highlights immune checkpoint inhibitors, CAR-T cell therapy, and monoclonal antibodies. Discussions include mechanisms of immune response and resistance. The session explores combination therapies for enhanced effectiveness. Advances in targeted drug delivery will also be discussed. Clinical outcomes and ongoing research will be reviewed. Participants will learn about next-generation therapies. Overall, this track focuses on innovative approaches to cancer treatment.

Track 6: Clinical Trials & Translational Cancer Research

This track focuses on bridging laboratory research with clinical applications. It highlights the design and execution of cancer clinical trials. Discussions include regulatory challenges and patient recruitment strategies. The session explores translating discoveries into effective treatments. Advances in trial methodologies will be covered. Ethical considerations in clinical research will be addressed. Participants will gain insights into real-world applications. Overall, this track supports faster innovation in cancer therapies.

Track 7: Early Detection, Screening & Diagnostic Technologies

This track emphasizes the importance of early cancer detection for improved survival rates. It covers advanced screening methods and diagnostic tools. Discussions include imaging technologies and liquid biopsies. The role of biomarkers in early diagnosis will be highlighted. Innovations in non-invasive detection techniques will be explored. The session also addresses accessibility and affordability challenges. Participants will gain knowledge of emerging diagnostic solutions. Overall, this track promotes proactive cancer management.

Track 8: Radiation Oncology & Advanced Radiotherapy Techniques

This track focuses on modern radiation therapy approaches in cancer treatment. It highlights precision radiotherapy and image-guided techniques. Discussions include advancements in dose optimization and treatment planning. The session explores minimizing damage to healthy tissues. Emerging technologies like proton therapy will be covered. Clinical outcomes and safety measures will be discussed. Participants will learn about next-generation radiotherapy solutions. Overall, this track enhances effective cancer treatment strategies.

Track 9: Surgical Oncology & Minimally Invasive Procedures

This track explores advanced surgical techniques in cancer treatment. It highlights minimally invasive and robotic-assisted surgeries. Discussions include improved patient recovery and reduced complications. The session covers innovations in surgical planning and precision. Advances in tumor removal techniques will be presented. Integration with other treatment modalities will be discussed. Participants will gain insights into modern surgical practices. Overall, this track focuses on improving surgical outcomes.

Track 10: Hematologic Malignancies & Blood Cancers

This track focuses on cancers affecting blood and bone marrow. It covers leukaemia, lymphoma, and multiple myeloma. Discussions include diagnosis, treatment strategies, and disease management. Advances in targeted therapies and stem cell transplantation will be explored. The session highlights challenges in treating blood cancers. Emerging research and clinical outcomes will be discussed. Participants will gain insights into innovative therapies. Overall, this track supports advancements in hematologic oncology.

Track 11: Breast, Lung, Colorectal & Prostate Cancer Studies

This track covers the most prevalent types of cancers worldwide. It highlights recent research in diagnosis, treatment, and prevention. Discussions include risk factors and screening strategies. Advances in targeted therapies will be explored. The session focuses on improving survival and quality of life. Clinical case studies and outcomes will be presented. Participants will gain practical insights into treatment approaches. Overall, this track addresses major global cancer challenges.

Track 12: Pediatric Oncology & Rare Cancers

This track focuses on cancers affecting children and rare cancer types. It highlights unique challenges in diagnosis and treatment. Discussions include specialized therapies and patient care strategies. Advances in research for rare cancers will be explored. The session emphasizes improving survival rates in pediatric cases. Ethical considerations in treatment will be addressed. Participants will gain insights into innovative care approaches. Overall, this track supports advancements in specialized oncology fields.

Track 13: Cancer Prevention, Lifestyle & Public Health

This track emphasizes strategies to reduce cancer risk through prevention. It covers lifestyle factors such as diet, exercise, and tobacco control. Discussions include public health policies and awareness programs. The role of early intervention will be highlighted. The session explores community-based prevention strategies. Global initiatives for cancer control will be discussed. Participants will gain insights into reducing cancer burden. Overall, this track promotes healthier populations.

Track 14: Oncology Nursing & Palliative Care

This track focuses on patient-centered care in oncology nursing. It highlights pain management and supportive care strategies. Discussions include improving quality of life for cancer patients. The session covers emotional and psychological support. Advances in palliative care practices will be explored. The role of nurses in treatment and recovery will be emphasized. Participants will gain practical care insights. Overall, this track enhances compassionate cancer care.

Track 15: Pharma Innovations & Drug Discovery in Oncology

This track explores advancements in cancer drug development. It highlights new therapeutic agents and treatment approaches. Discussions include drug design, testing, and approval processes. The session covers challenges in oncology drug discovery. Emerging technologies in pharmaceutical research will be discussed. Collaboration between industry and academia will be emphasized. Participants will gain insights into future drug innovations. Overall, this track drives progress in cancer therapeutics.

Track 16: Digital Health, Telemedicine & Oncology Data Science

This track focuses on digital transformation in cancer care. It highlights telemedicine and remote patient monitoring. Discussions include data analytics and health informatics. The session explores improving access to care through technology. Challenges in data security and integration will be addressed. Emerging digital tools in oncology will be showcased. Participants will gain insights into modern healthcare solutions. Overall, this track promotes technology-driven cancer care.

Absract Review Process

Our abstract review process ensures academic excellence, transparency, and fair evaluation:

• Submission: Authors submit their abstracts through the official online submission portal.
• Pre-Screening: The editorial team reviews each submission for relevance to oncology and cancer research, along with clarity, structure, and adherence to guidelines.
• Double-Blind Evaluation: Each abstract is evaluated by independent experts in oncology, cancer research, and related clinical or scientific fields to ensure unbiased assessment.

         Scoring Criteria:

•   Scientific merit and originality
• Clinical or research significance in oncology
• Methodological accuracy and clarity
• Relevance to the conference theme and tracks

• Decision & Notification: Accepted abstracts are categorized into Oral, Poster, or Virtual Presentation formats. Authors will receive official notification along with reviewer feedback where applicable.
• Revision Process: Authors may be requested to revise their abstracts based on expert suggestions to meet quality standards.
• Early Acceptance Advantage: Early submissions are prioritized in the conference program, helping authors secure preferred presentation slots and greater visibility.

VISA Process

To ensure a smooth and hassle-free travel experience, participants are advised to begin their visa application process well in advance of the conference dates:

Determine Visa Type: Identify the appropriate visa category (typically a Schengen short-stay visa) based on your purpose of visit to attend the conference in France.

Conference Invitation Letter: Registered participants can request an official invitation letter from the conference organizers, which can be used to support the visa application process.

Application Submission: Submit your visa application through the respective French Embassy or authorized visa application center in your country, along with all required documents.

Required Documents:

• Valid passport (with sufficient validity)
• Completed visa application form
• Passport-size photographs
• Proof of conference registration
• Invitation letter from the organizers
• Travel itinerary (flight bookings)
• Accommodation details
• Proof of financial support

Visa Processing Time: Processing times may vary, so applicants are encouraged to apply at least 4–8 weeks prior to the conference.

Important Note: The conference organizers are not responsible for visa approvals or rejections. Participants are advised to comply with all embassy requirements and apply early to avoid delays.

Proper planning and timely submission will help ensure a smooth journey to attend the conference in Paris.

Market Analysis

The global oncology market continues to expand at a remarkable pace, driven by the rising incidence of cancer, growing awareness of early detection, and continuous advancements in treatment technologies. Increasing investments in research and development, along with the adoption of precision medicine and personalized therapies, are reshaping how cancer is diagnosed and treated worldwide. The shift toward patient-centered care and innovative therapeutic approaches is creating significant opportunities for healthcare providers, researchers, and industry stakeholders.

• The global oncology market is projected to surpass USD 450 billion by 2030, growing at a strong CAGR driven by demand for advanced therapies and diagnostics.
• Immunotherapy and targeted therapies are leading the transformation of cancer treatment, offering more effective and less invasive solutions.
• Liquid biopsy and early detection technologies are gaining traction, enabling non-invasive cancer diagnosis and real-time disease monitoring.
• Artificial intelligence and machine learning are revolutionizing oncology by enhancing imaging, predictive analytics, and clinical decision-making.
• Pharmaceutical and biotechnology collaborations are rapidly increasing, focusing on drug discovery, clinical trials, and companion diagnostics.
• Emerging markets, particularly in Asia-Pacific, are witnessing significant growth due to improving healthcare infrastructure and rising cancer awareness.

This conference serves as a vital platform for researchers, clinicians, and industry leaders to explore these evolving market trends, build strategic collaborations, and accelerate innovations that will shape the future of global cancer care.